Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Treatment of Upper Extremity Deep-Vein Thrombosis.

Trial Profile

Treatment of Upper Extremity Deep-Vein Thrombosis.

Phase of Trial: Phase IV

Latest Information Update: 15 Feb 2013

At a glance

  • Drugs Dalteparin sodium (Primary)
  • Indications Deep vein thrombosis
  • Focus Therapeutic Use
  • Most Recent Events

    • 28 Feb 2012 Actual patient number is 67 according to ClinicalTrials.gov.
    • 28 Feb 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 07 Feb 2011 Planned end date changed from 1 Sep 2009 to 1 Dec 2011 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top